Abstract
Urgent Need to Maintain Patient Treatment Rates Drives Technological
Advancements in Clinical Laboratory Analyzers Markets
The clinical laboratory analyzers markets comprise various analyzers that
perform diagnostic tests to monitor common bodily parameters and diagnose
diseases. With these instruments becoming increasingly sophisticated,
healthcare institutions are recognizing greater value in them for the
improvement of disease management and patient success rates. The resultant
escalating demand for quick and accurate results will inflict greater pressure
on clinical laboratory operations. As a result, these analyzers are expanding
system capabilities and introducing technological advancements to provide
comprehensive testing solutions that facilitate efficient, accurate, and
streamlined laboratory procedures.
This Frost & Sullivan study evaluates the development of emerging technologies
in the U.S. clinical laboratory analyzers markets. It also examines the
challenges participants are likely to face in this space and offers strategic
recommendations for the same. The study provides an in-depth look into the
following market segments: clinical chemistry, immunoassay, integrated,
hematology, hemostasis, and blood gas analyzers. In addition, it details the
revenues, growth, and market share analysis of these segments.
Despite Laboratory Consolidation and System Replacements, Manufacturers
Continue to Provide High-quality Analyzers
"Due to saturation, these markets rely on system replacements instead of sale
of new equipment to generate revenues; also, laboratory consolidation is a
trend that decreases new placements for manufacturers," according to the
analyst of this study. "To remain competitive, manufacturers need to focus
their attention on improvements to instrumentation, including enhancements in
automation, integration, throughput, and ease of use."
Despite increasing numbers of leases and reagent rental contracts, expanded
menus that add value to laboratories by minimizing maintenance requirements
encourage widespread uptake of these analyzers. Also, manufacturers provide
instruments that are efficient, accurate, lower costs, and simplify processes
to increase productivity of laboratories and thereby encourage demand.
Next-generation Instrumentation with Comprehensive Testing Capabilities Needed
to Combat Emergence of Competitive Technologies
Shortage of skilled personnel and advancement in alternative technologies,
such as molecular diagnostics analyzers, point-of-care instruments, and home
testing devices is causing concern to manufacturers in these mature markets.
Although these factors sound challenging, they promote technological
enhancements to clinical laboratory analyzer features and testing
capabilities, thereby improving the quality of instruments produced. To remain
competitive, manufacturers are designing smaller, fully automated, and highly
sophisticated systems that are easy to use, provide networking solutions, and
facilitate efficient data management.
"In future, retaining market share is likely to depend on providing solutions
that address customer concerns over staffing shortages, higher testing
volumes, space constraints, cost pressures, and workflow management," notes
the analyst. "Additionally, the clinical laboratory analyzer markets are
experiencing a trend toward testing consolidation, which is creating demand
for integrated systems with expanded capabilities, thereby securing the future
for next-generation laboratory analyzers."
View Cart
